End Stage Renal Disease (Hemodialysis). Chronic kidney disease, stage 5 Chronic uraemia End stage kidney disease: in allograft failure NOS on dialysis without dialysis or transplant
Conditions
Interventions
Intervention 1: Intervention 1: CoQ10 100 mg oral capsules, Dosage: 100 mg once daily, Duration: Three months. Intervention 2: Intervention 2 (control group): No treatment, Duration: Three months.
Treatment - Drugs
Intervention 1: CoQ10 100 mg oral capsules, Dosage: 100 mg once daily, Duration: Three months
Intervention 2 (control group): No treatment, Duration: Three months
Sponsors
Vice chancellor for research, Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients who are undergoing regular hemodialysis for at least 3 months will be entered. Exclusion criteria: Being in active infection phase, having autoimmune diseases, consuming immunosuppressive medications or warfarin, pregnancy, breast feeding
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum concentration of interleukin 6. Timepoint: At baseline and at the end of the study. Method of measurement: ELISA kit.;Serum concentration of interleukin 33. Timepoint: At baseline and at the end of the study. Method of measurement: ELISA kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse effects. Timepoint: During the study. Method of measurement: Patients' report. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Sharifi Negad
Kerman University of Medical Sciences
Outcome results
None listed